A Study to Compare Two Paracetamol Tablets
NCT01381640 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2016-07-06
Summary
This is a single dose pharmacoscintigraphic study investigating the differences in paracetamol absorption between two formulations.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
Marketed paracetamol
marketed formulation
- DRUG
-
Experimental paracetamol formulation
Experimental formulation
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Pharmacokinetic Study to Compare Two Formulations of Paracetamol
NCT01767428 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations
NCT01568749 ·Status: COMPLETED ·Phase: PHASE1
-
At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations
NCT01551836 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of an Experimental Paracetamol Formulation
NCT01476176 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations
NCT03562780 ·Status: COMPLETED ·Phase: PHASE1
-
Post-operative Dental Pain Study Comparing Analgesic Efficacy
NCT01082081 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study of Paracetamol.
NCT03953287 ·Status: UNKNOWN ·Phase: PHASE1
-
PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
NCT01997112 ·Status: COMPLETED ·Phase: PHASE4
-
Paracetamol Discontinuation in the Elderly After Long-term Consumption
NCT04523740 ·Status: UNKNOWN ·Phase: NA
-
Effect of Paracetamol on the Common Cold
NCT01277081 ·Status: COMPLETED ·Phase: PHASE2
-
Paracetamol as Antipyretic and Analgesic Medication
NCT01070732 ·Status: COMPLETED ·Phase: PHASE4
-
A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects
NCT05022810 ·Status: COMPLETED ·Phase: PHASE1
-
NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management
NCT03222518 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo Effect of Paracetamol in Healthy Volunteers
NCT01053650 ·Status: COMPLETED ·Phase: PHASE1
-
Ibuprofen and Paracetamol Pharmacokinetic Study
NCT02452450 ·Status: COMPLETED ·Phase: PHASE1
-
To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine
NCT01112462 ·Status: COMPLETED ·Phase: PHASE1
-
Paracetamol Effect on Prostaglandins and Blood Pressure
NCT06235320 ·Status: NOT_YET_RECRUITING
-
Analgesic Effect of Paracetamol, Paracetamol + Codeine, Ibuprofen and Their Combination
NCT00921700 ·Status: COMPLETED ·Phase: PHASE4
-
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI
NCT01586962 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study
NCT03451487 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions
NCT06855576 ·Status: COMPLETED ·Phase: PHASE1
-
A New Formulation of Intravenous Paracetamol for Fever Management
NCT02283203 ·Status: COMPLETED ·Phase: PHASE4
-
Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study
NCT02262702 ·Status: WITHDRAWN
-
Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache
NCT01842633 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Two Doses of a Common Cold Treatment on Alertness
NCT01686646 ·Status: COMPLETED ·Phase: PHASE3